TABLEĀ 1

Description of the patients enrolled in the study

PatientAge (yr)GenderHIV viral load
(copies/ml)
CD4 count
(mm3)
Yr of
diagnosis
ART regimen
151MUndetectable1,2142008Epzicom, atazanavir/ritonavir
259MUndetectable7662006Darunavir, dolutegravir, truvada
446MUndetectable1532011Elvitegravir, tonofovir, emtricitabine, ALA
563M<207902008Efavirenz, emtricitabine, tenofovir
654M<206982008Abacavir, dolutegravir, lamivudine
858M<209162014Abacavir, lamivudine
966M<204172011Efavirenz, emtricitabine, tenofovir
1063M<204452008Truvada, emtricitabine, tenofovir
1160M641842011Truvada, emtricitabine, tenofovir
1251M<204412005Nevirapine, lamivudine, and azidovudin
1366M682881989Abacavir, dolutegravir, lamivudine
1446M<205142015Emtricitabine, rilpivirine, tenofovir, ALA
1552M<201,1912008Ritonavir, atazanavir
1652M19271482008Ritonavir, darunavir
1762M<204301999Truvada, maraviroc
1945MUndetectable8801994Atazanavir, ritonavir
2044M<209292012Emtricitabine, rilpivirine, tenofovir, ALA
2147M931,6451999Lopinavir, ritonavir
2249F<209042006Abacabir, dolutegravir